Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Beta Interferon
... at a CAGR of 3.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$943.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is ... Read More
-
Stem Cell Therapy for Multiple Sclerosis Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... Sclerosis from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, ... Read More
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
... projected to to expand to a value of USD 3.02 billion in 2030 from USD 1.40 billion in 2024, with a significant CAGR of 13.6%. The autoinjector finished formulations market is projected to surge to ... Read More
-
U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type (IVD, LDT), By Technology (Immunoassays, Clinical Chemistry, Hematology, Coagulation, Microbiology), By Application, By Country, And Segment Forecasts, 2024 - 203
... 2030 U.S. IVD And LDT For Autoimmune Diseases Market Growth & Trends The U.S. IVD and LDT for autoimmune diseases market size is expected to reach USD 3.70 billion by 2030, growing at a CAGR ... Read More
-
Neurorehabilitation Devices Market Report by Product Type (Neurorobotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interface), Application (Stroke, Multiple Sclerosis, Parkinson's Disease, Cerebral Palsy, and Others), End User (Hospitals and Clinics, Cognitive Care Centers, and Others), and Region 2024-2032
... and Region 2024-2032 The global neurorehabilitation devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2032, exhibiting a growth rate (CAGR) of ... Read More
-
Multiple Sclerosis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Mesenchymal Stem Cells Market - forecast to 2033 : By SOURCE (Bone Marrow-derived, Adipose Tissue-derived, Umbilical Cord Blood-derived, Peripheral Blood, Dental Pulp, Fetal Liver, Lung), APPLICATION (Bone Regeneration, Cartilage Repair, Osteoarthritis Treatment, Myocardial Infarction Treatment, Ischemic Heart Diseases, Immune System Disorders, Inflammatory Disorders, Gastrointestinal Disorders, Neurological Disorders), TYPE (Autologous, Allogeneic), PROCESSING TECHNIQUE (Cell Sourcing & Isolation, Expansion and Sub-culture, Cryopreservation, Differentiation, Characterization), DELIVERY MODE (Intra-articular Injections, Intravenous Infusion), R&D STATUS (Pre-clinical Studies, Clinical Trials - Phase I, Clinical Trials - Phase II, Clinical Trials - Phase III), DIESEASES (Diabetes, Multiple Sclerosis, Liver Cirrhosis, Stroke, Spinal Cord Injury, Respiratory Disorders), THERAPEUTIC APPLICATION (Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicol
... Ischemic Heart Diseases, Immune System Disorders, Inflammatory Disorders, Gastrointestinal Disorders, Neurological Disorders), TYPE (Autologous, Allogeneic), PROCESSING TECHNIQUE (Cell Sourcing & Isolation, Expansion and Sub-culture, Cryopreservation, Differentiation, Characterization), DELIVERY MODE (Intra-articular Injections, Intravenous Infusion), R&D STATUS ... Read More
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD), Regional Outlook– Global Forecast up to 2030
... most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to help you develop previously unheard-of levels of business acumen. The company's primary ... Read More
-
Global Multiple Sclerosis Treatment Market Report and Forecast 2024-2032
... grow at a CAGR of 4.10 % during the forecast period of 2024-2032, driven by advances in understanding individual genetic markers. The market is experiencing robust growth and is expected to reach USD 30.6 billion ... Read More
-
Global Specialty Pharmaceuticals Market 2024-2028
... report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Multiple Sclerosis Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... USD 35.16 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029). The global multiple sclerosis therapeutics market size is expected to grow from USD 30.03 billion in 2023 to USD ... Read More
-
2024 Global: Multiple Sclerosis Therapeutics Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Neurological Biomarkers Market, By Biomarker Type (Artificial Tears, Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers), By Application (Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Neurological biomarkers help in objectively measuring and evaluating normal biological and pathogenic processes. These aid in detecting neurological ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Secondary Progressive Multiple Sclerosis (SPMS) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Secondary Progressive Multiple Sclerosis (SPMS), historical and forecasted epidemiology as well as the Secondary Progressive Multiple Sclerosis (SPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Primary Progressive Multiple Sclerosis (PPMS) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Primary Progressive Multiple Sclerosis (PPMS), historical and forecasted epidemiology as well as the Primary Progressive Multiple Sclerosis (PPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Myelin Regeneration in Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034
... the Myelin Regeneration in Multiple Sclerosis, historical and forecasted epidemiology as well as the Myelin Regeneration in Multiple Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Chronic Progressive Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034
... Progressive Multiple Sclerosis, historical and forecasted epidemiology as well as the Chronic Progressive Multiple Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Progressive Multiple ... Read More
-
Multiple Sclerosis Therapeutics Market - 2024-2031
... forecast period 2024-2031. Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord (central nervous system). With MS, the immune system mistakenly attacks myelin cells. These are the protective covers (sheaths) ... Read More
-
Multiple Sclerosis Therapeutics
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Immunomodulators, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$13.2 Billion by the ... Read More
-
Multiple Sclerosis Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 21.33 billion in 2023, and the market is now projected to grow from USD 21.16 billion in 2024 to USD 38.94 billion by 2032, exhibiting a CAGR of 7.9% during the forecast ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Global Autoinjectors Market Size study & Forecast, by Application (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others), Type (Disposable Autoinjectors and Reusable Autoinjectors), End User (Home Care Settings, Hospital and Clinics, and Others), and Regional Analysis, 2023-2030
... 2023-2030 Global Autoinjectors Market is valued approximately USD 8 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.05% over the forecast period 2023-2030. Autoinjectors are medical devices ... Read More
-
Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
Research Assistance
